This Serial Entrepreneur Wants The FDA To Approve His AI Doctor

Bloomwell, a German telehealth company, is a key player in the country's growing $900 million cannabis industry. Founded in 2020, it initially faced challenges with paper-based prescriptions and manual delivery. Today, Bloomwell connects over 100,000 patients with 60 doctors, utilizing proprietary software for electronic prescriptions and fast delivery. The company has achieved profitability, with significant revenue and a 30% margin, estimating $55 million in annual revenue. Bloomwell experienced a 3,300% growth in prescriptions from 2024 to 2025 and anticipates distributing 25-30 tons of cannabis in 2026. Holding 15-20% market share in Germany, Bloomwell operates similarly to US telehealth platforms, offering a convenient, digital experience for patients. Beyond prescriptions, Bloomwell generates revenue by selling software and data to healthcare professionals and wholesalers. They also cross-sell ancillary products. Investors see Bloomwell's data capabilities and its role in expanding the global cannabis market as its core value.